Top Feed
Cero Therapeutics faces NASDAQ delisting
CERo Therapeutics Announces Listing on OTC Markets
CERo Therapeutics (NASDAQ: CERO) denied over $2.5M equity rule; suspended Oct. 31
Battle for client assets heats up as brokers cut fees to zero
CERO Stock Price and Chart — OTC:CERO
Zero-day options and financial market vulnerability
CERo Therapeutics (CERO) Short Interest & Short Float | Updated Apr 2026
CERo doses sixth patient in CER-1236 trial, expands study By Investing.com
Cero Trade approved as first Latin American I-REC platform operator
Why Is CERo Therapeutics Stock Down 80% Today?
CERo Therapeutics stock fell hard on Thursday following a delisting notice.
Cero Therapeutics faces NASDAQ delisting
Cero Therapeutics is facing potential delisting from NASDAQ due to non-compliance with the exchange's minimum bid price requirement.
CERo Therapeutics Announces Listing on OTC Markets
Company's Shares Will Continue to Trade Under Ticker CERO on the OTC Markets SOUTH SAN FRANCISCO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE)...
CERo Therapeutics (NASDAQ: CERO) denied over $2.5M equity rule; suspended Oct. 31
Nasdaq Panel denies CERo's continued listing; trading suspended Oct 31. Company seeks Council review, pursues OTC, and reports $2.25M closed...
Battle for client assets heats up as brokers cut fees to zero
The race to zero appears to be nearing the finish line after several brokerage giants cut commissions on all US equities, options and ETFs in the last few...
CERO Stock Price and Chart — OTC:CERO
View live CERo Therapeutics Holdings, Inc. chart to track its stock's price action. Find market predictions, CERO financials and market news.
Zero-day options and financial market vulnerability
Bowen Xiao Zero-day options have exploded in popularity in recent years, accounting for approximately half of S&P 500's total options volume...
CERo Therapeutics (CERO) Short Interest & Short Float | Updated Apr 2026
Are hedge funds shorting CERo Therapeutics (NASDAQ:CERO) stock? View the latest CERO short interest ratio, short volume, and more at MarketBeat.
CERo doses sixth patient in CER-1236 trial, expands study By Investing.com
SOUTH SAN FRANCISCO, Calif. - CERo Therapeutics Holdings, Inc. (OTCQB:CERO) has dosed the sixth patient in its Phase 1 clinical trial of...
Cero Trade approved as first Latin American I-REC platform operator
The I-TRACK Foundation has approved Cero Trade, a Chilean marketplace for...
TRADING CERO
@TradingCero
27250
Stats
23064
Rank
27.2K
Points
0
Videos
11
Articles
0
Reviews
0
Comments
Profile
Groups
This member is not part of any groups yet.